{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-23-015843","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2023-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.567380+00:00","generated_at":"2026-06-07T08:49:31.616483+00:00","sec_items":["8.01","9.01"],"event_type":"dividend","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Pharma-Bio Serv declares special dividend of $0.075 per share, payable Feb 15, 2024","bullets":["Board approved a special dividend of $0.075 per share.","Payable on or about February 15, 2024 to shareholders of record January 30, 2024.","Dividend is in addition to any regular quarterly dividend; amount not disclosed.","Company provides compliance and consulting services to pharma, biotech, and allied industries."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-23-015843","json":"https://secwatch.observer/filing/0001654954-23-015843.json","markdown":"https://secwatch.observer/filing/0001654954-23-015843.md","text":"https://secwatch.observer/filing/0001654954-23-015843.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423015843/0001654954-23-015843-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495423015843/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T08:49:31.616483+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}